Who Owns Longs Drugs?

• Parent Company: CVS Health
• Ownership Type: Acquired
• Acquisition Year: 2012
• Company Type: Publicly Traded
• Stock Ticker: NYSE: CVS

• Founded: 1928
• Founders: Joseph Long
• Acquired by CVS Health: 2012

• Founded: 1963
• Headquarters: Woonsocket, Rhode Island, USA
• Company Type: Publicly Traded
• Stock: NYSE: CVS
• Revenue: $402.1 billion (FY2025)
• Employees: Approximately 300,000

Visit CVS Health website

• Headquarters: Woonsocket, Rhode Island, USA
• Manufacturing / Operations: United States

Longs Drugs operates under CVS Health's comprehensive sustainability framework, which integrates environmental responsibility, ethical business practices, and community health initiatives across all pharmacy operations. The brand's sustainability efforts focus on reducing environmental impact while maintaining accessible healthcare services and supporting community well-being in Hawaii and the western United States.

Environmental Sustainability and Healthy Planet Initiatives: As part of CVS Health's Healthy 2030 strategy, Longs Drugs contributes to the company's ambitious environmental goals. CVS Health has established comprehensive sustainability targets across four pillars: Healthy People, Healthy Business, Healthy Community, and Healthy Planet. The company's 2024 Impact Report details progress toward environmental goals including waste reduction, energy efficiency improvements, and sustainable pharmacy operations. Longs Drugs locations implement these initiatives through energy-efficient store designs, waste reduction programs, and sustainable product sourcing.

Pharmacy Waste Management and Responsible Disposal: Longs Drugs participates in CVS Health's comprehensive medication disposal programs and environmental stewardship initiatives. The company implements proper pharmaceutical waste management, including safe disposal of expired medications and environmentally responsible handling of pharmacy waste. These programs help prevent environmental contamination while supporting community health and safety. CVS Health's sustainability reporting includes detailed metrics on waste reduction and responsible disposal practices across all pharmacy locations.

Sustainable Store Operations: Longs Drugs has implemented green building practices and energy-efficient technologies in its retail locations. The company focuses on reducing energy consumption through LED lighting, efficient HVAC systems, and renewable energy adoption where feasible. CVS Health's sustainability initiatives include increasing the percentage of non-medical waste recycled and implementing comprehensive recycling programs across all retail locations, including Longs Drugs stores.

Ethical Business Practices and Compliance: Longs Drugs maintains strict adherence to pharmaceutical regulations and ethical business practices. The company operates under comprehensive compliance programs that ensure proper prescription handling, patient privacy protection, and ethical business conduct. CVS Health's governance structure includes oversight mechanisms that hold the company accountable for ethical performance and transparent business practices across all operations.

Community Health and Accessibility: Longs Drugs demonstrates commitment to community health through localized healthcare services and accessible pharmacy care. The brand's integration with local Hawaiian communities includes partnerships with local organizations, support for community health initiatives, and investment in healthcare accessibility. Longs Drugs maintains strong relationships with local suppliers and community organizations, supporting economic sustainability while ensuring rapid response during normal operations and emergencies.

Supply Chain Sustainability: Longs Drugs works with suppliers who share CVS Health's commitment to environmental and ethical standards. The company emphasizes local sourcing when possible, supporting the Hawaiian economy and reducing transportation emissions. Longs Drugs partners with prominent local distributors including Webco Advantage Hawaii, S & K Sales Company, and The Islander Group to maintain sustainable supply chain practices while ensuring product availability and community support.

Longs Drugs has received recognition for its community leadership, healthcare services, and commitment to Hawaii's residents, reflecting the brand's deep integration into Hawaiian communities and its role as a trusted healthcare provider.

Community Leadership Recognition: Longs Drugs has earned generations of trust as Hawaii's leading healthcare and wellness retailer, receiving acknowledgment from local business organizations and community groups for its sustained commitment to community health. The brand's uniquely localized business model, which integrates in-store and online services for convenience while partnering with local organizations, has been recognized as an effective approach to community healthcare delivery.

Healthcare Innovation Awards: Longs Drugs has been acknowledged for healthcare innovation through its comprehensive pharmacy services and accessible care models. The brand's integration with CVS Pharmacy's advanced healthcare services, including prescription refills, same-day Rx delivery, and convenient care options, has received recognition for improving healthcare accessibility in Hawaiian communities.

Business Excellence Recognition: Business View Magazine has featured Longs Drugs for its dedication to community support and healthcare innovation. The company's founding in 1938 and subsequent growth to approximately 500+ locations demonstrates sustained business excellence while maintaining community-focused values. Longs Drugs' ability to balance commercial success with community responsibility has been acknowledged as a model for retail pharmacy operations.

Customer Trust and Loyalty Recognition: Longs Drugs has received recognition for building and maintaining customer trust across generations of Hawaiian residents. The brand's consistent presence in local communities, combined with its commitment to personalized pharmacy services, has resulted in strong customer loyalty and recognition as a trusted healthcare provider.

Local Economic Impact Recognition: Longs Drugs has been acknowledged for its positive impact on the Hawaiian economy through local sourcing practices and community investment. The company's partnerships with local suppliers and distributors support economic sustainability while ensuring rapid response during emergencies and normal operations. These contributions to the local economy have been recognized by business organizations and community leaders.

Integration with CVS Health Excellence: As part of CVS Health, Longs Drugs benefits from and contributes to the parent company's recognition for healthcare innovation and sustainability leadership. CVS Health's comprehensive sustainability programs and healthcare initiatives have received industry recognition, reflecting positively on all CVS Health pharmacy locations including Longs Drugs stores.

Longs Drugs, as part of CVS Health, has faced significant legal challenges primarily related to opioid dispensing practices and regulatory compliance issues. These controversies have drawn substantial scrutiny and resulted in major financial settlements affecting the entire CVS Health organization.

Opioid Crisis Litigation and Settlement: CVS Health, including its Longs Drugs subsidiary, has been involved in major litigation related to the opioid crisis. In December 2022, CVS agreed to pay approximately $5 billion over 10 years to settle thousands of lawsuits claiming the company contributed to the opioid epidemic by dispensing opioid drugs despite obvious red flags. This settlement was part of a broader $13 billion agreement involving CVS, Walgreens, and Walmart to resolve more than 3,000 lawsuits from states, municipalities, and Native American tribes.

Department of Justice Lawsuit: In December 2024, the U.S. Department of Justice filed a nationwide lawsuit against CVS Pharmacy Inc. and various subsidiaries, including Longs Drugs operations. The civil complaint, unsealed in Providence, Rhode Island, alleges that CVS knowingly filled unlawful prescriptions for controlled substances in violation of the Controlled Substances Act (CSA) and sought reimbursement from federal healthcare programs. The Justice Department claims CVS continued to dispense suspicious opioid prescriptions despite obvious red flags, contributing to the ongoing opioid crisis.

Regulatory Compliance Issues: The Department of Justice lawsuit highlights systemic compliance issues across CVS Health's pharmacy operations, including Longs Drugs locations. The complaint alleges that CVS failed to implement adequate systems to identify and prevent suspicious prescription orders, despite having access to prescription monitoring programs and other tools designed to detect potential diversion and abuse.

Financial Impact and Business Consequences: The opioid litigation has resulted in significant financial costs for CVS Health, affecting the company's profitability and shareholder value. The $5 billion settlement, combined with ongoing legal defense costs and potential additional penalties, represents a substantial financial burden that affects all CVS Health subsidiaries including Longs Drugs.

Reputational Damage: The opioid crisis involvement has damaged CVS Health's reputation as a trusted healthcare provider. The lawsuits and settlement have raised questions about the company's commitment to patient safety and responsible pharmacy practices, potentially affecting customer trust across all CVS Health locations including Longs Drugs stores.

Enhanced Compliance Requirements: As a result of these controversies, CVS Health has implemented enhanced compliance programs and monitoring systems across all pharmacy locations. These changes include stricter prescription monitoring, enhanced staff training, and improved systems for identifying suspicious prescription orders. Longs Drugs locations must comply with these enhanced requirements as part of the CVS Health network.

Community Impact in Hawaii: The opioid crisis has particularly affected Hawaiian communities, and Longs Drugs' involvement in the litigation has raised concerns among local community leaders and healthcare providers. The company's role in the opioid dispensing controversy has affected its relationships with local healthcare organizations and community groups in Hawaii.